Home

Welcome to MyIDSA

Welcome to MyIDSA, IDSA’s Member-Only Community! Connect with Colleagues, Share Resources, Start or Join a Lively Discussion. Join us…It’s Infectious!

JOIN THE DISCUSSION

Recent Discussions

  • Profile Picture

    Global HIV & TB Community

    By: Thomas Quinn , 20 days ago
    Posted in: IDea Exchange

    Good Morning, I'm excited to announce the launch of the Global HIV & TB Community. This community was created so members can discuss thoughts and news on global HIV and tuberculosis responses, research and development, policy and other pertinent issues ...

    1 person recommends this.
  • Profile Picture

    RE: Hyperbaric Medicine as a second specialty for ID ...

    By: Irving Jacoby , 14 hours ago
    Posted in: IDea Exchange

    Thank you, Cora, for your confirmation of the positive outcome for ID physicians who become knowledgeable about hyperbaric oxygen therapy, and get involved with its use for infections.  It's not just for anaerobic infections. It works on the immune response ...

  • Profile Picture

    RE: OPAT in drug users

    By: Joseph Pulvirenti , 17 hours ago
    Posted in: IDea Exchange

    we are struggling with the same problem of IDUs with deep seated infections (osteomylelitis and endocarditis) requiring long term IV therapy. The current accepted strategy is either they stay in the hospital for the full course of therapy or receive their ...

New Guidelines Update

Healthcare-Associated Ventriculitis and Meningitis

Image Credit: National Library of Medicine

Practice Guidelines

Member Spotlight

Sophia Koo, MD, SM, FIDSA has been selected as a semifinalist in the first round of the U.S. Department of Health and Human Services (HHS) Antimicrobial Resistance Diagnostic Challenge, a $20 million federal prize competition seeking innovative, rapid point-of-care laboratory diagnostic tests to combat the development and spread of drug resistant bacteria. Dr. Koo will receive $50,000 to develop her concept, “Breath volatile metabolites for the rapid identification of pneumonia etiology,” into a prototype. The proposal outlines a novel approach to community acquired pneumonia (CAP) diagnosis based on distinct differences in the breath volatile metabolite profiles of patients with bacterial vs. viral pneumonia.

Dr. Koo is with Harvard Medical and the Dana-Farber Cancer Institute and is a member of IDSA’s Diagnostics Committee.

News

  • As White House appoints pro-vaccine officials, plan for safety commission appears stalled

    21 hours ago

    Robert Kennedy Jr., the environmental activist and leading vaccine skeptic, says that it has been months since he has talked with White House ...

  • State health officials monitor uptick in whooping cough cases, encourage continued immunization

    21 hours ago

    Maryland public health officials, monitoring an uptick in the number of whooping cough cases, are urging parents to make sure children are immunized ...

Help attract the best and brightest to the field of infectious diseases.

IDSA Education and Research
Foundation

Donate Today

Upcoming Events


  • Saturday
    26
    August

    2017 Infectious Disease Board Review Course

    Saturday, August 26 - Wednesday, August 30, 2017
    IDBR is an essential destination for physicians planning to certify or recertify in the Infectious Disease Subspecialty of the American Board of Internal Medicine. Each year more than 450 attendees join our renowned faculty for four and a half days of expert lectures, interactive courses, and insightful looks into contemporary medicine. The 2017 Live Course comes with a full catalog of online materials including online-only presentations, downloadable MP3 lectures, study guides, examination prep-questions, and our Pass Guarantee provision. This course is also suitable for physicians planning to take Infectious Disease sections of the Internal Medicine Board Examination.

    Contact Information

    Tyson's Corner, VA

  • Wednesday
    25
    October

    Infectious Diseases in Primary Care

    Wednesday, October 25 - Friday, October 27, 2017
    This acclaimed course provides a comprehensive ID update. Led by Harvard Medical School's leading ID faculty and clinicians, this program provides guidance to improve the diagnosis, prevention, and treatment of infectious diseases. Participants learn the practice implications of important new innovations and ensure that their ability to address ID challenges is fully current.
    Boston, MA

IDSA has been important in my career in infectious disease. IDSA also plays a big role in advocacy and drawing attention to key issues. It's exciting to be a part of that and feel that I have an avenue for my voice to be heard.
Ingrid Bassett, MD, MPH, FIDSA
The idea that I could link epidemiology with my fundamental knowledge of how microorganisms work, along with diagnostic microbiology...this is an amazing way to put the pieces of the puzzles together about how infectious diseases work in human beings.
Lucy Tompkins, MD, PhD, FIDSA
I always like mystery stories growing up and you have to be very astute...You have to look at the symptoms, the geography, the home and social situation to solve the mystery of their problem.
Susan Bleasdale, MD
You can take a patient in front of you, and within a short amount of time with your clinical care, have an enormous impact.
John Lynch, MD, MPH
Understanding the pathogenesis of infectious diseases requires a knowledge of pathology, immunology, especially microbiology. The discipline allows practitioners to combine all of those, and there's never a dull moment.
Philip Polgreen, MD, MPH
I just became a member of IDSA this year, and I find it amazing how supportive IDSA has been to me so far.
Noah Kojima, MD